Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.04B |
| 2 |
Gaotu Techedu
GOTU
|
+$1.03B |
| 3 |
Visa
V
|
+$749M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$517M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$515M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$4.43B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.58B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$759M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$643M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.23% |
| 2 | Consumer Discretionary | 8.46% |
| 3 | Healthcare | 7.67% |
| 4 | Financials | 7.46% |
| 5 | Communication Services | 6.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OSG
2326
Octave Specialty Group
OSG
$222M
| $11.5M | ﹤0.01% |
746,257
+16,844
| +2% | +$248K |
|
2327
Brookfield Infrastructure
BIPC
$4.85B
| $11.5M | ﹤0.01% |
238,065
-1,941
| -0.8% | -$82.2K |
|
2328
Littelfuse
LFUS
$11.6B
| $11.5M | ﹤0.01% |
45,053
-49,652
| -52% | -$11M |
|
2329
CALL
Southwest Airlines
LUV
$23B
| $11.5M | ﹤0.01% |
246,100
+96,100
| +64% | +$4.16M |
|
|
ATVI
2330
CALL
DELISTED
Activision Blizzard
ATVI
| $11.5M | ﹤0.01% |
123,400
-3,000
| -2% | -$244K |
|
2331
iShares S&P Small-Cap 600 Value ETF
IJS
$8.34B
| $11.5M | ﹤0.01% |
140,888
+49,664
| +54% | +$3.61M |
|
|
RVNC
2332
DELISTED
Revance Therapeutics, Inc.
RVNC
| $11.5M | ﹤0.01% |
404,126
-48,490
| -11% | -$1.26M |
|
2333
Fresenius Medical Care
FMS
$12.9B
| $11.4M | ﹤0.01% |
275,289
-38,938
| -12% | -$1.62M |
|
|
MIK
2334
DELISTED
Michaels Stores, Inc
MIK
| $11.4M | ﹤0.01% |
875,855
-1,580,015
| -64% | -$16.1M |
|
2335
CALL
Duke Energy
DUK
$97.3B
| $11.4M | ﹤0.01% |
124,200
+35,800
| +40% | +$3.31M |
|
2336
CALL
United Parks & Resorts
PRKS
$2.12B
| $11.4M | ﹤0.01% |
360,000
-180,000
| -33% | -$4.69M |
|
2337
Element Solutions
ESI
$9.23B
| $11.4M | ﹤0.01% |
640,961
+9,610
| +2% | +$133K |
|
2338
ALX Oncology
ALXO
$283M
| $11.3M | ﹤0.01% |
131,628
+124,247
| +1,683% | +$7.47M |
|
|
CNR
2339
Core Natural Resources Inc
CNR
$4.45B
| $11.3M | ﹤0.01% |
1,571,055
+144,369
| +10% | +$756K |
|
2340
Urban Edge Properties
UE
$2.73B
| $11.3M | ﹤0.01% |
874,685
-808,864
| -48% | -$9.71M |
|
2341
CALL
Thermo Fisher Scientific
TMO
$220B
| $11.3M | ﹤0.01% |
24,300
+700
| +3% | +$328K |
|
|
AFMD
2342
DELISTED
Affimed
AFMD
| $11.3M | ﹤0.01% |
194,414
+167,172
| +614% | +$7.87M |
|
2343
NOV
NOV
$7B
| $11.3M | ﹤0.01% |
824,040
-983,728
| -54% | -$11.1M |
|
2344
PUT
Fidelity National Information Services
FIS
$22.1B
| $11.3M | ﹤0.01% |
79,900
+16,400
| +26% | +$2.34M |
|
2345
John B. Sanfilippo & Son
JBSS
$972M
| $11.3M | ﹤0.01% |
143,000
-24,379
| -15% | -$1.85M |
|
2346
CALL
TAL Education Group
TAL
$6.87B
| $11.3M | ﹤0.01% |
157,700
| – | – |
|
2347
Celldex Therapeutics
CLDX
$3.27B
| $11.3M | ﹤0.01% |
642,303
+539,046
| +522% | +$9.7M |
|
2348
First Commonwealth Financial
FCF
$2.17B
| $11.3M | ﹤0.01% |
1,028,340
-73,598
| -7% | -$705K |
|
2349
PUT
GameStop
GME
$8.6B
| $11.2M | ﹤0.01% |
2,375,200
+1,336,000
| +129% | +$4.6M |
|
2350
Appian
APPN
$2.54B
| $11.2M | ﹤0.01% |
68,936
+23,291
| +51% | +$2.61M |
|
Similar funds
Goldman Sachs's Q4 2020 Portfolio in Review
As of Q4 2020, Goldman Sachs held 5,916 positions worth $389B, up 10% from $352B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Goldman Sachs withdrew a net $17.4B in Q4 2020, closing 466 positions and reducing 2,520 holdings. Its most notable exit was Immunomedics Inc, an estimated $418M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Goldman Sachs opened a new position in Chindata Group Holdings Limited American Depositary Shares worth $290M.
- Goldman Sachs's largest Q4 2020 buy was Chindata Group Holdings Limited American Depositary Shares: 12,107,899 shares worth $290M.
- Goldman Sachs added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2020, an estimated $1.04B increase.
- Goldman Sachs's biggest Q4 2020 reduction was Tesla, cutting an estimated $4.43B.
- Goldman Sachs fully exited Immunomedics Inc in Q4 2020, selling an estimated $418M.
- Goldman Sachs's ten largest holdings make up 20% of its $389B portfolio in Q4 2020.
- Goldman Sachs opened 643 new positions and closed 466 in Q4 2020.
- Goldman Sachs's portfolio value rose 10% quarter-over-quarter to $389B.
Based on Goldman Sachs's 13F filing for Q4 2020, filed 12 Feb 2021.